These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
656 related items for PubMed ID: 24399815
21. [Analysis of paraoxonase activity and lipid profile in lupus patients]. Kiss E, Seres I, Zsolt K, Tarr T, Csípo I, Szegedi G, Paragh G. Orv Hetil; 2005 Nov 20; 146(47):2395-402. PubMed ID: 16398152 [Abstract] [Full Text] [Related]
22. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Yavuz DG, Yüksel M, Deyneli O, Ozen Y, Aydin H, Akalin S. Clin Endocrinol (Oxf); 2004 Oct 20; 61(4):515-21. PubMed ID: 15473886 [Abstract] [Full Text] [Related]
23. Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus. Dasgupta S, Demirci FY, Dressen AS, Kao AH, Rhew EY, Ramsey-Goldman R, Manzi S, Kammerer CM, Kamboh MI. BMC Med Genet; 2011 Jan 11; 12():7. PubMed ID: 21223581 [Abstract] [Full Text] [Related]
24. Assessing the relationship of paraoxonase-1 Q192R polymorphisms and the severity of lung disease in SM-exposed patients. Golmanesh L, Bahrami F, Pourali F, Vahedi E, Wahhabaghai H, Mehrani H, Ghanei M. Immunopharmacol Immunotoxicol; 2013 Jun 11; 35(3):419-25. PubMed ID: 23672526 [Abstract] [Full Text] [Related]
25. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia. Fridman O, Gariglio L, Riviere S, Porcile R, Fuchs A, Potenzoni M. Arch Cardiol Mex; 2016 Jun 11; 86(4):350-357. PubMed ID: 27640339 [Abstract] [Full Text] [Related]
26. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus. Tripi LM, Manzi S, Chen Q, Kenney M, Shaw P, Kao A, Bontempo F, Kammerer C, Kamboh MI. Arthritis Rheum; 2006 Jun 11; 54(6):1928-39. PubMed ID: 16729301 [Abstract] [Full Text] [Related]
27. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects. Sirivarasai J, Kaojarern S, Yoovathaworn K, Sura T. Chem Biol Interact; 2007 Jul 20; 168(3):184-92. PubMed ID: 17532308 [Abstract] [Full Text] [Related]
28. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Delgado Alves J, Ames PR, Donohue S, Stanyer L, Nourooz-Zadeh J, Ravirajan C, Isenberg DA. Arthritis Rheum; 2002 Oct 20; 46(10):2686-94. PubMed ID: 12384928 [Abstract] [Full Text] [Related]
29. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients. Jiang XL, Li M, Zhou JG, Yang QB, Du LJ, Du J. Cell Biochem Biophys; 2011 Nov 20; 61(2):461-6. PubMed ID: 21748243 [Abstract] [Full Text] [Related]
30. Genotype and phenotype frequencies of paraoxonase 1 in fertile and infertile men. Tavilani H, Fattahi A, Esfahani M, Khodadadi I, Karimi J, Bahrayni E, Vatannejad A, Vaisi-Raygani A, Ghorbani M, Latifi Z. Syst Biol Reprod Med; 2014 Dec 20; 60(6):361-6. PubMed ID: 25264968 [Abstract] [Full Text] [Related]
31. The relation of PON1-L55M gene polymorphism and clinical manifestation of Behcet's disease. Dursun A, Cicek S, Keni FM, Karakas-Celik S, Sezer T, Altinyazar CH. Acta Biochim Pol; 2014 Dec 20; 61(2):271-4. PubMed ID: 24936519 [Abstract] [Full Text] [Related]
32. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Mahmoud RA, El-Gendi HI, Ahmed HH. Clin Biochem; 2005 Feb 20; 38(2):134-41. PubMed ID: 15642275 [Abstract] [Full Text] [Related]
33. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus. López P, Rodríguez-Carrio J, Martínez-Zapico A, Pérez-Álvarez ÁI, López-Mejías R, Benavente L, Mozo L, Caminal-Montero L, González-Gay MA, Suárez A. Thromb Haemost; 2017 Nov 20; 117(11):2194-2206. PubMed ID: 29044294 [Abstract] [Full Text] [Related]
35. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine. Yıldırım S, Akar S, Kuyucu M, Yıldırım A, Dane S, Aygül R. Cell Biochem Funct; 2011 Oct 20; 29(7):549-54. PubMed ID: 21755523 [Abstract] [Full Text] [Related]
37. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population. Gupta N, Binukumar BK, Singh S, Sunkaria A, Kandimalla R, Bhansali A, Gill KD. Gene; 2011 Nov 01; 487(1):88-95. PubMed ID: 21803130 [Abstract] [Full Text] [Related]
38. Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus. Kiss E, Seres I, Tarr T, Kocsis Z, Szegedi G, Paragh G. Ann N Y Acad Sci; 2007 Jun 01; 1108():83-91. PubMed ID: 17893973 [Abstract] [Full Text] [Related]
39. Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1. Ferretti G, Bacchetti T, Campanati A, Simonetti O, Liberati G, Offidani A. Br J Dermatol; 2012 Jan 01; 166(1):204-7. PubMed ID: 21790517 [Abstract] [Full Text] [Related]
40. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects. Vekic J, Kotur-Stevuljevic J, Jelic-Ivanovic Z, Spasic S, Spasojevic-Kalimanovska V, Topic A, Zeljkovic A, Stefanovic A, Zunic G. Eur J Clin Invest; 2007 Sep 01; 37(9):715-23. PubMed ID: 17696961 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]